CTI
  • UNITED STATES INVESTORS
  • Share
  • About Us
    • Vision & Values
    • Leadership
    • History
    • Collaborations
    • In the Community
    • Careers
    • Media Gallery
    • Contact CTI
  • Products
    • PIXUVRI®
  • Development
    • Pipeline
    • Pacritinib
    • Pixantrone
    • Tosedostat
    • Publications
  • Clinical Trials
    • Clinical Trial Overview
    • Physician Resources
    • Patient Resources
  • Investitori
    • Overview
    • Comunicati Stampa
    • Il Titolo
      • Grafico interattivo
      • Quotazioni Storiche
      • Calcola Investimenti
      • Agente depositario
    • SEC
    • Informazioni agli azionisti
      • Assemblea degli Azionisti
      • Internal Dealings (Form 4)
      • Avvisi obbligatori
      • Altri docomenti societari
    • Copertura Analisti
    • Presentazioni e webcast
    • Bilanci
    • Dati Consolidati
      • Statistiche
      • Stato Patrimoniale
      • Conto Economico
      • Rendiconto Finanziario Annuale
      • Indici
    • Corporate Governance
      • Comitati
      • Leadership Bios
      • Consiglio d’Amministrazione
      • Governance Documents
    • FAQ
    • Richiesta Informazioni
    • Email Alert

Investitori

  • Overview
  • Comunicati Stampa
  • Il Titolo
    • Grafico interattivo
    • Quotazioni Storiche
    • Calcola Investimenti
    • Agente depositario
  • SEC
  • Informazioni agli azionisti
    • Internal Dealings (Form 4)
    • Avvisi obbligatori
    • Altri documenti societari
    • Assemblea degli Azionisti
  • Copertura Analisti
  • Presentazioni e webcast
  • Bilanci
  • Dati Consolidati
    • Statistiche
    • Stato Patrimoniale
    • Conto Economico
    • Rendiconto Finanziario Annuale
    • Indici
  • Corporate Governance
    • Comitati
    • Leadership Bios
    • Consiglio d’Amministrazione
    • Governance Documents
  • FAQ
  • Richiesta Informazioni
  • Email Alert

Info Tools

    • Stampa
    • Invia
  • RSS Feeds
  • Email Alert
  • Contatti
  • Scheda

Most Viewed Links

  • SEC
  • Informazioni agli azionisti

Definition

<< Back
Price to Revenue (TTM)
This is the current Price divided by the Sales Per Share for the trailing twelve months. If there is a preliminary earnings announcement for an interim period that has recently ended, the revenue (sales) values from this announcement will be used in calculating the trailing twelve month revenue per share.

About CTI

  • Vision & Values
  • Leadership
  • History
  • Collaborations
  • In the Community
  • Careers
  • Media Kit
  • Contact CTI
  • Request Information

Products

  • PIXUVRI®

Development

  • Pipeline
  • Pacritinib
  • Pixantrone
  • Tosedostat
  • Paclitaxel Poliglumex
  • Publications

Clinical Trials

  • Clinical Trials Overview
  • Physician Resources
  • Patient Resources
  • Adverse Event Information

Investors

  • Investors Overview
  • News
  • Stock
  • SEC Filings
  • Analyst Coverage
  • Events & Webcasts
  • Annual Report
  • Financial Details
  • Corporate Governance
  • Investor FAQ

Conquering cancer. That's in our blood.

  • Follow us!
  • © 2019 CTI BioPharma Corp. CTI BioPharma and "Conquering cancer. That’s in our blood." are trademarks of CTI BioPharma Corp.
  • Terms of Use
  • Privacy Policy